Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Yale University79 enrolled

Overview

This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Obesity Binge Eating

Interventions

Xenical + behavioral interventionDRUG

120 mg TID; Behavioral weight loss in Spanish

Behavioral intervention + placeboBEHAVIORAL

Behavioral weight loss treatment in Spanish Placebo TID

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Monolingual Spanish Speaking * Obese (BMI \>= 30) Exclusion Criteria: * Pregnancy * Current cardiac disease * Serious neurologic illnesses

Locations (2)

Hispanic Clinic of the Connecticut Mental Health Center

New Haven, Connecticut, United States

Yale Department of Psychiatry

New Haven, Connecticut, United States

Outcomes

Primary Outcomes

Participant BMI

Body Mass Index (BMI)

Time frame: 4 months and 6 month follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.